• Home
  • Stocks
  • Bharat Immunologicals & Biologicals Corporation Ltd.

Bharat Immunologicals & Biologicals Corporation Ltd.

View in App
26.69 +0.65 ▲2.5%

06 December 2023, 04:01:00 PM
Volume: 110,632

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bibcol.com
Market Cap 115.25 Cr.
Enterprise Value(EV) 180.70 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -3.95 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-03
Industry PE 38.60 Trailing Twelve Months Ending 2023-03
Book Value / Share -7.65 Trailing Twelve Months Ending 2023-03
Price to Book Value -3.49 Calculated using Price: 26.69
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 4.32 Cr. 43,180,000 Shares
FaceValue 10
About Bharat Immunologicals & Biologicals Corporation Ltd.
The Company's principal activity is to manufacture and supply of oral polio vaccine. It supplies oral polio vaccine to Government of India. Its plant is located in Bulandshahr, Uttar Pradesh.

Bharat Immunologicals & Biologicals Corporation Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Bharat Immunologicals & Biologicals Corporation Ltd. Performance

View details >>
1 Day
+2.50%
1 Week
-1.15%
1 Month
+12.43%
3 Month
+3.61%
6 Month
+17.84%
1 Year
-2.95%
2 Year
-46.78%
5 Year
+116.29%
10 Year
+144.19%

Bharat Immunologicals & Biologicals Corporation Ltd. Fundamental Ratios

View details >>
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 15.68 3.81 -16.25 16.94 -10.76 -17.00 -39.93 -158.64
Return on Capital Employed (%) 42.29 9.07 -8.52 31.11 -17.52 -10.70 -21.87 -73.05 -8.08
Return on Assets (%) 7.28 1.81 -8.50 10.80 -8.51 -7.22 -8.97 -18.41 -6.35

Bharat Immunologicals & Biologicals Corporation Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 41 35 42 38 31 20 34 105 88 79
Non Curr. Liab. 4 1 -1 -5 -4 -8 -14 -15 -20 -19
Curr. Liab. 35 30 14 13 88 101 64 101 91 99
Minority Int.
Equity & Liab. 80 66 55 45 115 113 84 192 159 158
Non Curr. Assets 7 6 8 7 16 20 50 126 126 126
Curr. Assets 74 60 47 38 99 93 34 65 33 33
Misc. Exp. not W/O
Total Assets 80 66 55 45 115 113 84 192 159 158

Bharat Immunologicals & Biologicals Corporation Ltd. Profit and Loss

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 203 146 128 124 35 84 67 85 78 26
Other Income 6 1 1 1 1 4 1 2 1 1
Total Income 209 147 129 125 36 88 68 87 79 27
Total Expenditure -191 -143 -132 -111 -43 -93 -77 -106 -83 -43
PBIDT 18 4 -3 14 -7 -5 -9 -19 -4 -16
Interest -6 -1 -6 -4 -1 -2 -5 -5 -6 -7
Depreciation -1 -1 -1 -1 0 0 0 0 0 0
Taxation -5 -1 3 -3 4 2 4 6 1 6
Exceptional Items
PAT 6 2 -6 7 -4 -6 -10 -18 -9 -17
Adjusted EPS 1 0 -1 2 -1 -1 -2 -4 -2 -4

Bharat Immunologicals & Biologicals Corporation Ltd. Cash Flow

View details >>
Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 31 -12 8 -9 -17 3 -32 34 12 -42
Cash Fr. Inv. 0 0 0 1 1 1 1 1 1 1
Cash Fr. Finan. 0 -6 -1 -2 -3 -3 31 -34 -12 45
Net Change 31 -18 7 -10 -20 1 -1 1 0 3
Cash & Cash Eqvt 41 23 30 20 0 1 0 1 1 5

Bharat Immunologicals & Biologicals Corporation Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25 59.25
Public 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75 40.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Bharat Immunologicals & Biologicals Corporation Ltd. Announcements

View details >>
Tue, 28 Nov 2023
Submission Of Notice Of 34Th Annual General Meeting On 29.12.2023 As Compliance Of The Provision Of LODR 2015.
Annual General Meeting of Shareholders for the year 2022-23 is scheduled to be held on 29.12.2023.Submitted for kind information and record please.
Tue, 28 Nov 2023
Compliance Of The Regulation Of LODR 2015 For The Intimation Of Book Closure Period (22.12.2023 To 29.12.2023) Of The Company In Respect Of 34Th Annual General Meeting Scheduled To Be Held On 29.12.2023.
Intimation of Book Closure in respect of AGM
Wed, 01 Nov 2023
Submission Of Unaudited Quarterly Financial Results Alongwith Limited Review Report For The Quarter Ended June 2023 As Compliance Of LODR 2015
submission of UAFR June 2023

Bharat Immunologicals & Biologicals Corporation Ltd. Technical Scans

View details >>
Wed, 06 Dec 2023
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
High Increase in 1 Month High Increase in 1 Month
High Increase in 5 Years High Increase in 5 Years
Tue, 05 Dec 2023
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above

Bharat Immunologicals & Biologicals Corporation Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,505.54 1,240.35 +0.1%
Divi's Laboratories Ltd. 99,132.60 3,734.45 -0.2%
Cipla Ltd. 97,689.40 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. 95,542.33 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. 79,632.26 5,543.10 -0.7%
Mankind Pharma Ltd. 78,289.00 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. 70,428.80 2,080.95 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.80 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 74.44 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-09 28.29 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.77 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.17 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 61.07 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.80 2,080.95 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.82 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-09 3.94 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.75 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.25 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.29 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.50 2,080.95 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,080.95 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.95 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.95 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,080.95 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,080.95 -0.9%

Bharat Immunologicals & Biologicals Corporation Ltd. FAQ's

What is Bharat Immunological share price?
Can I buy Bharat Immunological shares now?
What is the Market Cap of Bharat Immunological?
What is the 52 Week High and Low of Bharat Immunological?
What is the trend of Bharat Immunological share price?